![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, May 18, 2010 1:35:37 PM
Paclitaxel
Epirubicin
Irinotecan
Mitoxantrone
and now also Bicalitamide and Letrazole for the US markets (APP).
Not sure whether just the API (i.e Pactitacel,etc) is manufactured by Frensenius Kabi Oncology and then imported by APP as a intermediate to be used in the final BOM of the final injectable oncology product, ie. Paclitaxel Injection, USP or whether the injectable sterile manufacturing occurs at the Frensenius Kabi Oncology Manufacturing Plant in India and is then imported as a semi-finish product and APP does the final packaging and labeling for Sales and distribution in the US market. I think it is the 1st scenario since APP had to also go through the approval process for the final product of every different dose of the injectables.
Links:
APP products
http://www.appdrugs.com/ProductDetail.html?pfid=202&name=Paclitaxel_Injection_USP
Frensuis Kabi Oncology approced Products for the US:
http://www.fresenius-kabi-oncology.com/products_Canada.html
I will have take another look at the FDA approval for Bicalitamide to see how the relationship will be there.
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM